“We are attracted to the long-term growth trend of this industry,” Zell said. “ILTA is a high-quality, low-cost leader with advanced facilities and a seasoned leadership team. We look forward to partnering with management and the existing investors to continue to drive growth and value.”
According to EGI, demand for pulses is growing steadily due to population growth in emerging markets and consumer preferences for healthier lifestyles in developed countries. Pulses are non-GMO and gluten-free.
“We welcome EGI as an investment partner,” said Dan Burneski, chief executive officer and president of ILTA. “The firm’s financial support and long history of adding value to its investments will enhance our ability to expand our footprint in a global marketplace with strong demand for our products.”